Dr. Tom Patterson, chief of the Division of Infectious Diseases in the Long School of Medicine, was interviewed about a new study UT Health San Antonio and University Hospital are interested in joining. It is an “antibody cocktail” treatment. The remdesivir antiviral study he is leading also is mentioned.